RBC's Positive Forecast for Biogen Stock Linked to Anticipated Leqembi Sales Growth
Wednesday, 5 June 2024, 10:17
RBC's Analysis on Biogen's Stock Rating
Get an expert insight into RBC's continued positive rating for Biogen's stock, maintaining a favorable outlook.
Anticipation on Leqembi Sales
- Leqembi sales surge expected to drive Biogen's growth.
Projections for Biogen
- RBC predicts outperformance for Biogen.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.